Search - tctmd.com

Displaying 661 - 680 of 1590

Sort: Relevancy | Date

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

News Conference News ESC 2021

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

August 31, 2021

STEP Trial Supports Lower BP Goal in Older Patients With Hypertension

News Conference News ESC 2021

STEP Trial Supports Lower BP Goal in Older Patients With Hypertension

August 30, 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

News Conference News ESC 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Michael O'Riordan

August 27, 2021

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

Number of People With Hypertension Doubles Since 1990

News Daily News

Number of People With Hypertension Doubles Since 1990

August 26, 2021

USPSTF Lowers Screening Age for Diabetes, Prediabetes to 35 for Overweight Adults

News Daily News

USPSTF Lowers Screening Age for Diabetes, Prediabetes to 35 for Overweight Adults

August 25, 2021

Statins Positively Alter Coronary Plaque Composition

News Daily News

Statins Positively Alter Coronary Plaque Composition

Michael O'Riordan

August 23, 2021

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

August 20, 2021

ASCVD.food.insecurity.jpg

News Daily News

Food Insecurity Common Among Patients With ASCVD

Michael O'Riordan

August 18, 2021

Milrinone, Dobutamine Comparable for Cardiogenic Shock: DOREMI

News Daily News

Milrinone, Dobutamine Comparable for Cardiogenic Shock: DOREMI

August 10, 2021

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

News Daily News

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

August 04, 2021

Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited

News Daily News

Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited

Michael O'Riordan

August 03, 2021

July/August 2021 News Roundup

News Opinion CV Team Dispatch

July/August 2021 News Roundup

August 01, 2021

STROKE-VT: DOACs Cut Cerebrovascular Events After LV Arrhythmia Ablation

News Conference News HRS 2021

STROKE-VT: DOACs Cut Cerebrovascular Events After LV Arrhythmia Ablation

July 29, 2021

ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study

News Daily News

ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study

Michael O'Riordan

July 27, 2021

Statin Decisions Gain From Scoring of Coronary Artery Calcium: MESA

News Daily News

Statin Decisions Gain From Scoring of Coronary Artery Calcium: MESA

Yael L. Maxwell

July 21, 2021

Apixaban May Be Best DOAC for Frail, Older Patients With AF

News Daily News

Apixaban May Be Best DOAC for Frail, Older Patients With AF

July 19, 2021

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.